检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:周洁[1] 司兆学[1] 董红林[1] 梁海清[1] 蔡军伟[1] 单罢安[1] 杨晶[1]
机构地区:[1]第一军医大学分校病理教研室,广东广州510315
出 处:《中国慢性病预防与控制》2001年第2期72-74,共3页Chinese Journal of Prevention and Control of Chronic Diseases
摘 要:目的研究 OK- 432与 IL- 2抑制近交系小鼠 C5 7BL/ 6 L ewis肺癌 (L L C)的生长及 c- fos蛋白的表达。方法以 C5 7BL/ 6荷瘤 L L C小鼠为模型 ,观察 OK- 432联合 IL- 2对肿瘤发生、生长、转移的影响 ,体内对肿瘤细胞的作用及用抗鼠 c- fos单克隆抗体进行 SABC免疫组化技术半定量测定 c- fos在 L ewis肺癌原发灶中的表达。结果二者联用对肿瘤体积和重量的抑制作用明显增强 (P<0 .0 1) ,增强抑瘤率 (P<0 .0 5 ) ,肺转移灶数目明显减少。电镜下显示肿瘤灶中出现许多凋亡细胞 ,瘤细胞核染色质浓集成块 ,在核膜内呈新月形或环形排列 ,核膜清楚 ,瘤细胞内质网扩张 ,线粒体肿胀。c- fos在联合用药组与对照组比较明显减少 (P<0 .0 1)。结论 OK- 432与 IL- 2有明显的协同抗肿瘤活性 ,其杀瘤过程主要为对瘤细胞的直接或间接攻击 ,和促进体内对多种反应细胞的相互作用 ;部分原因可能阻抑 c- fos癌基因的表达 ;提示 OK- 432联合 IL-Objective To study inhibition effects of OK 432 and IL 2 on inbred C 57 BL/6 mice bearing Lewis lung cancer(LLC) growth and c fos protein expression.Methods Through establishing C 57 BL/6 mice bearing LLC model,we observed effects of OK 432 and IL 2 on tumor occurrence,growth,metastasis,tumor cell changes in vivo ,and the expression of c fos in primary tumor tissues with SABC immunohistochemical semiquantitative method.Results Combination administration significantly enhanced inhibition effects on tumor volume and weight versus control( P <0 01),and reduced the number of pulmonary metastasis loci.A lot of apoptosis cell emerged in the tumor loci under electronmicroscope.The expression of c fos significantly decreased in combination group versus that in control group( P <0 01).Conclusion OK 432 and IL 2 possessed obviously synergetic anti tumor effect,which mainly through attacking the tumor cell directly or indirectly,improved some kinds of cell interaction and partly by inhibiting c fos ongene expression;In a word,OK 432 and IL 2 might be an efficient biotherapy means for cancer patients in clinical.\;
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.114